Variable | Hazard ratio | 95% CI | p-value |
---|---|---|---|
Age at diagnosis (years) | 1.05 | 0.97–1.13 | 0.213 |
PSA (ng/ml) | |||
10–20 vs < 10 | 0.31 | 0.09–1.13 | 0.076 |
> 20 vs < 10 | 1.47 | 0.66–3.29 | 0.348 |
Stage | |||
T3-T4 vs T1-T2 | 0.82 | 0.31–2.38 | 0.687 |
Gleason Score | |||
> 7 vs ≤ 7 | 2.47 | 1.15–5.29 | 0.020* |
Site of metastasis at first progression | |||
Bone-only vs Loco/LN-only | 3.88 | 1.37–10.98 | 0.011* |
Visceral-only vs Loco/LN-only | 1.89 | 0.20–18.10 | 0.582 |
Multiple site vs Loco/LN-only | 3.56 | 1.24–10.24 | 0.019* |